Gene Therapies for Tumor Treatment Market Report

Gene Therapies for Tumor Treatment Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 22, 2020
  • PAGES：223
  • REPORT CODE：GMM480966
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Gene Therapies for Tumor Treatment market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.4% during the forecast period.

    This report presents the market size and development trends by detailing the Gene Therapies for Tumor Treatment market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gene Therapies for Tumor Treatment market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gene Therapies for Tumor Treatment industry and will help you to build a panoramic view of the industrial development.

    Gene Therapies for Tumor Treatment Market, By Type:

    • Gene Induced Immunotherapy

    • Oncolytic Virotherapy

    • Gene Transfer

    Gene Therapies for Tumor Treatment Market, By Application:

    • Hospital

    • Clinic

    • Other

    Some of the leading players are as follows:

    • Amgen

    • Sibiono

    • Kite Pharma

    • Shanghai Sunway

    • Novartis

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Gene Therapies for Tumor Treatment Market: Technology Type Analysis

    • 4.1 Gene Therapies for Tumor Treatment Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Gene Therapies for Tumor Treatment Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Gene Induced Immunotherapy

      • 4.3.2 Oncolytic Virotherapy

      • 4.3.3 Gene Transfer

    5 Gene Therapies for Tumor Treatment Market: Product Analysis

    • 5.1 Gene Therapies for Tumor Treatment Product Market Share Analysis, 2018 & 2026

    • 5.2 Gene Therapies for Tumor Treatment Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Gene Therapies for Tumor Treatment Market: Application Analysis

    • 6.1 Gene Therapies for Tumor Treatment Application Market Share Analysis, 2018 & 2026

    • 6.2 Gene Therapies for Tumor Treatment Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Clinic

      • 6.3.3 Other

    7 Gene Therapies for Tumor Treatment Market: Regional Analysis

    • 7.1 Gene Therapies for Tumor Treatment Regional Market Share Analysis, 2018 & 2026

    • 7.2 Gene Therapies for Tumor Treatment Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Amgen

      • 9.1.1 Amgen Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Sibiono

      • 9.2.1 Sibiono Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Kite Pharma

      • 9.3.1 Kite Pharma Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Shanghai Sunway

      • 9.4.1 Shanghai Sunway Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Novartis

      • 9.5.1 Novartis Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

     

    The List of Tables and Figures (Totals 99 Figures and 136 Tables)

    • Figure Gene Induced Immunotherapy Gene Therapies for Tumor Treatment market, 2015 - 2026 (USD Million)

    • Figure Oncolytic Virotherapy Gene Therapies for Tumor Treatment market, 2015 - 2026 (USD Million)

    • Figure Gene Transfer Gene Therapies for Tumor Treatment market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Clinic market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Gene Therapies for Tumor Treatment market, by country, 2015 - 2026 (USD Million)

    • Table North America Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table North America Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table North America Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Canada Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Canada Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Europe Gene Therapies for Tumor Treatment market, by country, 2015 - 2026 (USD Million)

    • Table Europe Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Europe Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Europe Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Germany Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Germany Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table France Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table France Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Italy Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Italy Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Spain Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Spain Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Gene Therapies for Tumor Treatment market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table China Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table China Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Japan Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Japan Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table India Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table India Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Gene Therapies for Tumor Treatment market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table MEA Gene Therapies for Tumor Treatment market, by country, 2015 - 2026 (USD Million)

    • Table MEA Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table MEA Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table MEA Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Gene Therapies for Tumor Treatment market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Gene Therapies for Tumor Treatment market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Gene Therapies for Tumor Treatment market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sibiono Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kite Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shanghai Sunway Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US